News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Dendreon Corporation Moving HQ to Selig Building on Waterfront
May 4, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Seattle Times -- Seattle biotech Dendreon, fresh off winning regulatory approval for its cancer therapy, confirmed Monday it's moving its headquarters and other local operations to a brand-new, bigger building.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
MORE ON THIS TOPIC
Earnings
Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings beat
May 5, 2026
·
2 min read
·
Annalee Armstrong
Earnings
Vertex’s quiet Q1 is calm before potentially ‘iconic’ renal evolution
May 5, 2026
·
2 min read
·
Tristan Manalac
IPO tracker
Odyssey eyes $236M for renewed Nasdaq bid, Seaport docks on Nasdaq
May 5, 2026
·
12 min read
·
Editorial Team
Manufacturing
Sertraline manufacturer recalls antidepressant batch after UK packaging mix-up
May 5, 2026
·
2 min read
·
Nick Paul Taylor
